Trading
Data
Solutions
Insights
About
ChromaCode is a biotechnology company that specializes in developing molecular diagnostics solutions. Founded in 2012 and headquartered in Carlsbad, California, the company's core technology is based on proprietary mathematical algorithms that enable the simultaneous detection of multiple DNA and RNA targets in a single reaction. ChromaCode harnesses the power of data science and advanced algorithms aiming to enhance the accuracy, efficiency, and affordability of diagnostic testing. Their solutions encompass infectious disease testing, genetic testing, oncology diagnostics, and more. The company works closely with clinical laboratories, healthcare providers, and regulatory agencies to ensure that their solutions meet rigorous quality standards and regulatory requirements.
ChromaCode is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
If you own ChromaCode pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.
Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.
ChromaCode is a private company and not publicly traded.
If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.
